Lymphocyte counts and the presence of specific lymphocyte subsets within tumors can serve as prognostic indicators. High levels of tumor-infiltrating lymphocytes (TILs), particularly CTLs, are generally associated with better outcomes in various cancers. Conversely, a low lymphocyte count, or lymphopenia, may indicate a poorer prognosis.
